Properties of the full random-effect modeling approach with missing covariate data
© 2023 Pharmetheus AB and The Authors. Statistics in Medicine published by John Wiley & Sons Ltd..
During drug development, a key step is the identification of relevant covariates predicting between-subject variations in drug response. The full random effects model (FREM) is one of the full-covariate approaches used to identify relevant covariates in nonlinear mixed effects models. Here we explore the ability of FREM to handle missing (both missing completely at random (MCAR) and missing at random (MAR)) covariate data and compare it to the full fixed-effects model (FFEM) approach, applied either with complete case analysis or mean imputation. A global health dataset (20 421 children) was used to develop a FREM describing the changes of height for age Z-score (HAZ) over time. Simulated datasets (n = 1000) were generated with variable rates of missing (MCAR) covariate data (0%-90%) and different proportions of missing (MAR) data condition on either observed covariates or predicted HAZ. The three methods were used to re-estimate model and compared in terms of bias and precision which showed that FREM had only minor increases in bias and minor loss of precision at increasing percentages of missing (MCAR) covariate data and performed similarly in the MAR scenarios. Conversely, the FFEM approaches either collapsed at ≥ $$ \ge $$ 70% of missing (MCAR) covariate data (FFEM complete case analysis) or had large bias increases and loss of precision (FFEM with mean imputation). Our results suggest that FREM is an appropriate approach to covariate modeling for datasets with missing (MCAR and MAR) covariate data, such as in global health studies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Statistics in medicine - 43(2024), 5 vom: 28. Feb., Seite 935-952 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nyberg, Joakim [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Covariate model |
|---|
| Anmerkungen: |
Date Completed 21.02.2024 Date Revised 25.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/sim.9979 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366187864 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366187864 | ||
| 003 | DE-627 | ||
| 005 | 20240326235141.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231227s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/sim.9979 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1348.xml |
| 035 | |a (DE-627)NLM366187864 | ||
| 035 | |a (NLM)38128126 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nyberg, Joakim |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Properties of the full random-effect modeling approach with missing covariate data |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.02.2024 | ||
| 500 | |a Date Revised 25.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 Pharmetheus AB and The Authors. Statistics in Medicine published by John Wiley & Sons Ltd. | ||
| 520 | |a During drug development, a key step is the identification of relevant covariates predicting between-subject variations in drug response. The full random effects model (FREM) is one of the full-covariate approaches used to identify relevant covariates in nonlinear mixed effects models. Here we explore the ability of FREM to handle missing (both missing completely at random (MCAR) and missing at random (MAR)) covariate data and compare it to the full fixed-effects model (FFEM) approach, applied either with complete case analysis or mean imputation. A global health dataset (20 421 children) was used to develop a FREM describing the changes of height for age Z-score (HAZ) over time. Simulated datasets (n = 1000) were generated with variable rates of missing (MCAR) covariate data (0%-90%) and different proportions of missing (MAR) data condition on either observed covariates or predicted HAZ. The three methods were used to re-estimate model and compared in terms of bias and precision which showed that FREM had only minor increases in bias and minor loss of precision at increasing percentages of missing (MCAR) covariate data and performed similarly in the MAR scenarios. Conversely, the FFEM approaches either collapsed at ≥ $$ \ge $$ 70% of missing (MCAR) covariate data (FFEM complete case analysis) or had large bias increases and loss of precision (FFEM with mean imputation). Our results suggest that FREM is an appropriate approach to covariate modeling for datasets with missing (MCAR and MAR) covariate data, such as in global health studies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a FREM | |
| 650 | 4 | |a covariate model | |
| 650 | 4 | |a full modeling approach | |
| 650 | 4 | |a global health | |
| 650 | 4 | |a height-for-age Z-score | |
| 700 | 1 | |a Jonsson, E Niclas |e verfasserin |4 aut | |
| 700 | 1 | |a Karlsson, Mats O |e verfasserin |4 aut | |
| 700 | 1 | |a Häggström, Jonas |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Statistics in medicine |d 1984 |g 43(2024), 5 vom: 28. Feb., Seite 935-952 |w (DE-627)NLM012664596 |x 1097-0258 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2024 |g number:5 |g day:28 |g month:02 |g pages:935-952 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/sim.9979 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2024 |e 5 |b 28 |c 02 |h 935-952 | ||